These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 3523114)
1. Trichosporonosis in patients with neoplastic disease. Walsh TJ; Newman KR; Moody M; Wharton RC; Wade JC Medicine (Baltimore); 1986 Jul; 65(4):268-79. PubMed ID: 3523114 [TBL] [Abstract][Full Text] [Related]
2. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Ruan SY; Chien JY; Hsueh PR Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711 [TBL] [Abstract][Full Text] [Related]
3. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Anaissie E; Gokaslan A; Hachem R; Rubin R; Griffin G; Robinson R; Sobel J; Bodey G Clin Infect Dis; 1992 Nov; 15(5):781-7. PubMed ID: 1445976 [TBL] [Abstract][Full Text] [Related]
4. [Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile]. Silva V; Zepeda G; Alvareda D Rev Iberoam Micol; 2003 Mar; 20(1):21-3. PubMed ID: 12825977 [TBL] [Abstract][Full Text] [Related]
5. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Matsue K; Uryu H; Koseki M; Asada N; Takeuchi M Clin Infect Dis; 2006 Mar; 42(6):753-7. PubMed ID: 16477548 [TBL] [Abstract][Full Text] [Related]
6. Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol. Krcmery V; Mateicka F; Kunová A; Spánik S; Gyarfás J; Sycová Z; Trupl J Support Care Cancer; 1999 Jan; 7(1):39-43. PubMed ID: 9926973 [TBL] [Abstract][Full Text] [Related]
7. Subcutaneous Infection Associated with Trichosporon ovoides: A Case Report and Review of Literature. Mohd Tap R; Sabaratnam P; Ramli NY; Hashim R; Mohd Fuat AR; Ng PP; Khairam H; Ahmad N Mycopathologia; 2016 Apr; 181(3-4):285-90. PubMed ID: 26493614 [TBL] [Abstract][Full Text] [Related]
8. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen. Dabas Y; Xess I; Kale P Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903 [TBL] [Abstract][Full Text] [Related]
9. [Drug susceptibility of Trichosporon beigelii isolated from urine and clinical features of their hosts]. Kouda M; Matsushima H; Homma S; Marumo K; Komine Y; Iizuka T Kansenshogaku Zasshi; 2003 Jul; 77(7):480-7. PubMed ID: 12931573 [TBL] [Abstract][Full Text] [Related]
10. [Disseminated Trichosporon beigelii infection: report of nine cases and review]. Tashiro T; Nagai H; Yamasaki T; Goto Y; Akizuki S; Nasu M Kansenshogaku Zasshi; 1993 Aug; 67(8):704-11. PubMed ID: 8409577 [TBL] [Abstract][Full Text] [Related]
11. [Nosocomial infection due to Trichosporon asahii: clinical revision of 22 cases]. Rodrigues Gda S; de Faria RR; Guazzelli LS; Oliveira Fde M; Severo LC Rev Iberoam Micol; 2006 Jun; 23(2):85-9. PubMed ID: 16854183 [TBL] [Abstract][Full Text] [Related]
12. Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia. Rieger C; Geiger S; Herold T; Nickenig C; Ostermann H Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):843-5. PubMed ID: 17690928 [TBL] [Abstract][Full Text] [Related]
13. Trichosporon beigelii, a new neonatal pathogen. Yoss BS; Sautter RL; Brenker HJ Am J Perinatol; 1997 Feb; 14(2):113-7. PubMed ID: 9259910 [TBL] [Abstract][Full Text] [Related]
14. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. Walsh TJ; Melcher GP; Rinaldi MG; Lecciones J; McGough DA; Kelly P; Lee J; Callender D; Rubin M; Pizzo PA J Clin Microbiol; 1990 Jul; 28(7):1616-22. PubMed ID: 2380383 [TBL] [Abstract][Full Text] [Related]
15. Colonization and infection with Trichosporon species in the immunosuppressed host. Haupt HM; Merz WG; Beschorner WE; Vaughan WP; Saral R J Infect Dis; 1983 Feb; 147(2):199-203. PubMed ID: 6827136 [TBL] [Abstract][Full Text] [Related]
16. Neonatal Trichosporon beigelii infection: report of a cluster of cases in a neonatal intensive care unit. Fisher DJ; Christy C; Spafford P; Maniscalco WM; Hardy DJ; Graman PS Pediatr Infect Dis J; 1993 Feb; 12(2):149-55. PubMed ID: 8426774 [TBL] [Abstract][Full Text] [Related]
17. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital. Araujo Ribeiro M; Alastruey-Izquierdo A; Gomez-Lopez A; Rodriguez-Tudela JL; Cuenca-Estrella M Rev Iberoam Micol; 2008 Dec; 25(4):221-5. PubMed ID: 19071890 [TBL] [Abstract][Full Text] [Related]
18. Trichosporon inkin as an Emergent Pathogen in Patients With Severe Pemphigus. Nobrega de Almeida Júnior J; Buccheri de Oliveira R; Duarte A; Lopes Motta A; Rossi F; Sachiko Yamamoto de Figueiredo D; Barbaro Del Negro GM; Aoki V; Wakisaka Maruta C; Giuli Santi C; Benard G JAMA Dermatol; 2015 Jun; 151(6):642-5. PubMed ID: 25785367 [TBL] [Abstract][Full Text] [Related]
19. Disseminated Trichosporon beigelii infection in patients with malignant diseases: immunohistochemical study and review. Tashiro T; Nagai H; Kamberi P; Goto Y; Kikuchi H; Nasu M; Akizuki S Eur J Clin Microbiol Infect Dis; 1994 Mar; 13(3):218-24. PubMed ID: 8050434 [TBL] [Abstract][Full Text] [Related]